Effects of obstructive sleep apnea on human spatial navigational memory processing in cognitively normal older individuals

Author(s):  
Anna E. Mullins ◽  
Masrai K. Williams ◽  
Korey Kam ◽  
Ankit Parekh ◽  
Omonigho M. Bubu ◽  
...  
SLEEP ◽  
2019 ◽  
Vol 42 (Supplement_1) ◽  
pp. A120-A120
Author(s):  
Anna E Mullins ◽  
Masrai K Williams ◽  
Korey Kam ◽  
Ankit Parekh ◽  
Bresne Castillo ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-11 ◽  
Author(s):  
Mihaela Teodorescu ◽  
David A. Polomis ◽  
Ronald E. Gangnon ◽  
Jessica E. Fedie ◽  
Flavia B. Consens ◽  
...  

Background/Objectives. Asthma in older individuals is poorly understood. We aimed to characterize the older asthma phenotype and test its association with obstructive sleep apnea (OSA).Design. Cross-sectional.Setting. Pulmonary and Asthma/Allergy clinics.Participants. 659 asthma subjects aged 18–59 years (younger) and 154 aged 60–75 (older).Measurements. Sleep Apnea scale of Sleep Disorders Questionnaire (SA-SDQ), asthma severity step (1–4, severe if step 3 or 4), established OSA diagnosis, continuous positive airway pressure (CPAP) use, and comorbidities.Results. Older versus younger had worse control, as assessed by asthma step, lung function, and inhaled corticosteroid use. Among older subjects, after controlling for known asthma aggravators, OSA diagnosis was the only factor robustly associated with severe asthma: on average, OSA was associated with nearly 7 times greater likelihood of severe asthma in an older individual (OR=6.67). This relationship was of greater magnitude than in younger subjects (OR=2.16). CPAP use attenuated the likelihood of severe asthma in older subjects by 91% (P=0.005), much more than in the younger asthmatics.Conclusion. Diagnosed OSA increases the risk for worse asthma control in older patients, while CPAP therapy may have greater impact on asthma outcomes. Unrecognized OSA may be a reason for poor asthma control, particularly among older patients.


SLEEP ◽  
2020 ◽  
Author(s):  
Jessica E Owen ◽  
Bryndis Benediktsdottir ◽  
Elizabeth Cook ◽  
Isleifur Olafsson ◽  
Thorarinn Gislason ◽  
...  

Abstract Obstructive sleep apnea (OSA) involves intermittent cessations of breathing during sleep. People with OSA can experience memory deficits and have reduced hippocampal volume; these features are also characteristic of Alzheimer’s disease (AD), where they are accompanied by neurofibrillary tangles (NFTs) and amyloid beta (Aβ) plaques in the hippocampus and brainstem. We have recently shown reduced hippocampal volume to be related to OSA severity, and although OSA may be a risk factor for AD, the hippocampus and brainstems of clinically verified OSA cases have not yet been examined for NFTs and Aβ plaques. The present study used quantitative immunohistochemistry to investigate postmortem hippocampi of 34 people with OSA (18 females, 16 males; mean age 67 years) and brainstems of 24 people with OSA for the presence of NFTs and Aβ plaques. OSA severity was a significant predictor of Aβ plaque burden in the hippocampus after controlling for age, sex, body mass index (BMI), and continuous positive airway pressure (CPAP) use. OSA severity also predicted NFT burden in the hippocampus, but not after controlling for age. Although 71% of brainstems contained NFTs and 21% contained Aβ plaques, their burdens were not correlated with OSA severity. These results indicate that OSA accounts for some of the “cognitively normal” individuals who have been found to have substantial Aβ burdens, and are currently considered to be at a prodromal stage of AD.


SLEEP ◽  
2017 ◽  
Vol 40 (suppl_1) ◽  
pp. A104-A104 ◽  
Author(s):  
K Gagnon ◽  
A Baril ◽  
J Montplaisir ◽  
J Carrier ◽  
C D’Aragon ◽  
...  

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A308-A308
Author(s):  
Omonigho Bubu ◽  
Arlener Turner ◽  
Ogie Umasabor-Bubu ◽  
Korey Kam ◽  
Anna Mullins ◽  
...  

Abstract Introduction Recent evidence suggests novel plasma Alzheimer’s Disease (AD) pathology biomarkers have high potential for AD risk prediction. We determined whether obstructive sleep apnea (OSA) severity is associated with plasma levels of Aβ40, Aβ42, Aβ42/Aβ40, Tau, tau/Aβ42 and NfL and whether this relationship is dependent of amyloid burden. Methods Cross-sectional analysis of baseline data from 120 community-dwelling, cognitively normal older-adults, selected from ongoing NYU prospective longitudinal studies on memory, sleep and aging. Of the 120 participants, 70 had baseline CSF-Aβ42 (measured using ELISA). OSA-severity was defined using AHI4% criteria. Levels of plasma Aβ40, Aβ42, Tau and NfL were determined using single molecule array technology ultra-sensitive assays. Associations of OSA-severity and plasma AD-biomarker levels (n=120) were assessed using Pearson correlation analysis. The association of OSA-severity and AD plasma biomarkers dependent on CSF-Aβ42 levels (n=70) was assessed using generalized linear models. Analyses were adjusted for age, sex, BMI, race, education and APOE4. Results Of the 120 participants, 80 (67%) were women. Mean (SD) age was 69.1 (7.2) years. Mean (SD) AHI was 14.3/hr. (16.3) {48 (40%) had AHI <5, 30 (25%) had AHI: 5 to ≤ 15, 18 (15%) had AHI: 15 to ≤30, and 22 (18%) had AHI >30}. Independent of amyloid-burden, OSA-severity was associated with higher levels of plasma Aβ40 (r=.21, p-value=.02), plasma Aβ42 (r=.26, p-value=.01), plasma Aβ42/Aβ40 (r=.20, p-value=.05), but not plasma Tau, plasma tau/Aβ42 or plasma NfL. The association of OSA-severity and plasma levels of Tau, Tau/Aβ42 or NfL dependent on CSF-Aβ42 levels revealed significant interactions between CSF-Aβ42 levels and AHI (p-value <.05 for all), with β-estimates suggesting that with combined increases in AHI and decreases in CSF-Aβ42 levels, there were corresponding increases in plasma levels of Tau, plasma Tau/Aβ42 or plasma NfL. The analysis was not powered for generating dichotomized strata specific (i.e. OSA+/Aβ+, OSA+/Aβ-, OSA-/Aβ+ and OSA-/Aβ-) estimates. Conclusion In this sample of cognitively-normal older- adults, OSA-severity was associated with levels of plasma Aβ40, Aβ42, Aβ42/Aβ40 and showed a synergistic effect with CSF Aβ42 on plasma levels of tau and NfL. Larger cohorts are necessary to delineate mechanisms and examine for OSA/Aβ strata-specific estimates. Support (if any) NIH/NIA/NHLBI (L30-AG064670, CIRAD-P30AG059303-Pilot, NYU-ADRC-P30AG066512-Developmental-Grant, AASM#231-BS-20)


2019 ◽  
Vol 12 (11) ◽  
pp. e232512 ◽  
Author(s):  
Shaobo Lei ◽  
Jonathan A Micieli

Non-arteritic anterior ischaemic optic neuropathy (NAION) is the most common acute optic neuropathy in older individuals but may also occur in younger patients. A 30-year-old man presented with a 2-day history of right eye painless vision loss and was found to have right optic disc oedema and a left ‘disc-at-risk’. He was diagnosed with right NAION and review of symptoms revealed witnessed apnea at night and episodes where he woke up gasping for air, concerning for obstructive sleep apnea (OSA). A formal sleep study revealed severe OSA and he was treated with continuous positive airway pressure to reduce his risk of fellow eye involvement and reduce his overall cardiovascular risk. OSA should be considered in every patient with NAION, especially in younger patients without any additional risk factors.


Sign in / Sign up

Export Citation Format

Share Document